{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:36:34Z","timestamp":1794645394249,"version":"4.9.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,18]]},"DOI":"10.1093\/jnci\/djt207","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T00:50:45Z","timestamp":1378255845000},"page":"1365-1372","source":"Crossref","is-referenced-by-count":69,"title":["Hormone Replacement Therapy and Breast Cancer: Heterogeneous Risks by Race, Weight, and Breast Density"],"prefix":"10.1093","volume":"105","author":[{"given":"Ningqi","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Dignam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezheng","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,9,3]]},"reference":[{"issue":"15","key":"key\n\t\t\t\t20170521020200_CIT0001","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1056\/NEJM199404143301508","article-title":"Hormonal treatment of postmenopausal women","volume":"330","author":"Belchetz","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20170521020200_CIT0002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"9084","key":"key\n\t\t\t\t20170521020200_CIT0003","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","journal-title":"Lancet"},{"issue":"9382","key":"key\n\t\t\t\t20170521020200_CIT0004","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"24","key":"key\n\t\t\t\t20170521020200_CIT0005","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2019s Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"key\n\t\t\t\t20170521020200_CIT0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"key\n\t\t\t\t20170521020200_CIT0007","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr1672","article-title":"Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women","volume":"9","author":"Jemal","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"3","key":"key\n\t\t\t\t20170521020200_CIT0008","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-007-9566-z","article-title":"Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy","volume":"107","author":"Katalinic","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"key\n\t\t\t\t20170521020200_CIT0009","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1158\/1055-9965.EPI-07-0546","article-title":"Changes in breast cancer incidence rates in the United States by histologic subtype and race\/ethnicity, 1995 to 2004","volume":"16","author":"Li","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"16","key":"key\n\t\t\t\t20170521020200_CIT0010","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","article-title":"The decrease in breast-cancer incidence in 2003 in the United States","volume":"356","author":"Ravdin","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t20170521020200_CIT0011","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"360","author":"Chlebowski","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"key\n\t\t\t\t20170521020200_CIT0012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"key\n\t\t\t\t20170521020200_CIT0013","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2217\/whe.11.42","article-title":"Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits","volume":"7","author":"Shoupe","year":"2011","journal-title":"Womens Health (Lond Engl)"},{"issue":"4","key":"key\n\t\t\t\t20170521020200_CIT0014","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jnci\/djq527","article-title":"Breast cancer risk in relation to the interval between menopause and starting hormone therapy","volume":"103","author":"Beral","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"key\n\t\t\t\t20170521020200_CIT0015","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"issue":"31","key":"key\n\t\t\t\t20170521020200_CIT0016","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1200\/JCO.2008.21.6432","article-title":"Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?","volume":"27","author":"Fournier","year":"2009","journal-title":"J Clin Oncol"},{"issue":"24","key":"key\n\t\t\t\t20170521020200_CIT0017","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1200\/JCO.2009.26.4770","article-title":"Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use","volume":"28","author":"Kerlikowske","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"key\n\t\t\t\t20170521020200_CIT0018","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archinte.166.7.760","article-title":"A prospective study of female hormone use and breast cancer among black women","volume":"166","author":"Rosenberg","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"key\n\t\t\t\t20170521020200_CIT0019","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/aje\/kwh331","article-title":"Comparative analysis of breast cancer risk factors among African-American women and white women","volume":"161","author":"Hall","year":"2005","journal-title":"AmJ Epidemiol"},{"issue":"12","key":"key\n\t\t\t\t20170521020200_CIT0020","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1210\/jc.2008-1272","article-title":"Approach to the patient with menopausal symptoms","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20170521020200_CIT0021","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2214\/ajr.169.4.9308451","article-title":"Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database","volume":"169","author":"Ballard-Barbash","year":"1997","journal-title":"Am J Roentgenol"},{"issue":"4","key":"key\n\t\t\t\t20170521020200_CIT0022","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/aje\/152.4.371","article-title":"Current medicolegal and confidentiality issues in large, multicenter research programs","volume":"152","author":"Carney","year":"2000","journal-title":"Am J Epidemio.l"},{"issue":"3","key":"key\n\t\t\t\t20170521020200_CIT0023","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7326\/0003-4819-138-3-200302040-00008","article-title":"Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography","volume":"138","author":"Carney","year":"2003","journal-title":"Ann Intern Med"},{"issue":"17","key":"key\n\t\t\t\t20170521020200_CIT0024","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/djj331","article-title":"Prospective breast cancer risk prediction model for women undergoing screening mammography","volume":"98","author":"Barlow","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"key\n\t\t\t\t20170521020200_CIT0025","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","article-title":"Multiple imputation of missing blood pressure covariates in survival analysis","volume":"18","author":"Van Buuren","year":"1999","journal-title":"Stat Med"},{"issue":"3","key":"key\n\t\t\t\t20170521020200_CIT0026","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1536867X0400400301","article-title":"Multiple imputation of missing values","volume":"4","author":"Royston","year":"2004","journal-title":"Stata J"},{"issue":"3","key":"key\n\t\t\t\t20170521020200_CIT0027","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1536867X0900900308","article-title":"Multiple imputation of missing values: further update of ice, with an emphasis on categorical variables","volume":"9","author":"Royston","year":"2009","journal-title":"Stata J"},{"issue":"4","key":"key\n\t\t\t\t20170521020200_CIT0028","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","journal-title":"Stat Med"},{"issue":"2","key":"key\n\t\t\t\t20170521020200_CIT0029","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10549-013-2434-0","article-title":"A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase","volume":"138","author":"Hou","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"key\n\t\t\t\t20170521020200_CIT0030","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/cncr.22723","article-title":"Reported drop in mammography: is this cause for concern?","volume":"109","author":"Breen","year":"2007","journal-title":"Cancer"},{"issue":"5","key":"key\n\t\t\t\t20170521020200_CIT0031","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ypmed.2008.06.010","article-title":"Recent trends in U.S. mammography use from 2000\u20132006: a population-based analysis","volume":"47","author":"Ryerson","year":"2008","journal-title":"Prev Med"},{"issue":"11","key":"key\n\t\t\t\t20170521020200_CIT0032","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S1470-2045(06)70911-1","article-title":"Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis","volume":"7","author":"Reeves","year":"2006","journal-title":"Lancet Oncol"},{"issue":"4","key":"key\n\t\t\t\t20170521020200_CIT0033","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"issue":"14","key":"key\n\t\t\t\t20170521020200_CIT0034","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"key\n\t\t\t\t20170521020200_CIT0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/oxfordjournals.aje.a113755","article-title":"Height and weight, mammographic features of breast tissue, and breast cancer risk","volume":"119","author":"Brisson","year":"1984","journal-title":"Am J Epidemiol"},{"issue":"1","key":"key\n\t\t\t\t20170521020200_CIT0036","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/95.1.30","article-title":"Postmenopausal hormone therapy and change in mammographic density","volume":"95","author":"Greendale","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"key\n\t\t\t\t20170521020200_CIT0037","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/dji279","article-title":"Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women\u2019s Health Initiative randomized trial","volume":"97","author":"McTiernan","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"key\n\t\t\t\t20170521020200_CIT0038","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/105\/18\/1365\/17312561\/djt207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:32:29Z","timestamp":1563841949000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djt207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,3]]},"references-count":38,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2013,9,3]]},"published-print":{"date-parts":[[2013,9,18]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djt207","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,3]]}}}